Results 41 to 50 of about 1,941,719 (257)

Enhancement of electrical conductivity associated with non-bridged oxygen defects in molybdenum phosphate oxide glass via doping of SrO

open access: yesScientific Reports, 2023
Based on the attractive properties of phosphate glass, improved molybdenum phosphate glasses of composition 40P2O5, 20MoO3, 15MgO, (25-x)Li2O, xSrO, [x = 0, 5, 10, 15 and 20 mol %] were prepared via the melt-quench technique. They were characterized by X-
A. M. Fayad   +3 more
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Experimental Glass Plant

open access: yes
Album A: The Toledo Glass Co., Experimental Glass Plant in Franklin, Pennsylvania (buildings). Irwing W.
Libbey-Owens-Ford Glass Company
core   +6 more sources

Decarbonizing Industrial Heat – A Comparison of Embodied Carbon for PV and Enclosed Parabolic Trough Systems

open access: yesSolarPACES Conference Proceedings
Heat accounts for more than half the world’s energy use. The largest user of heat is industry, and the pressure to decarbonize is high. Tendencies to “electrify everything” are seen everywhere, but electric energy is expensive for medium and high ...
Markus Balz   +2 more
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Enhanced luminescence at 2.88 and 2.04 μm from Ho3+/Yb3+ codoped low phonon energy TeO2–TiO2–La2O3 glass

open access: yesAIP Advances, 2019
The high phonon energy and short infrared cut-off wavelength of conventional oxide glass (or crystal) hosts are the limitations to achieve mid-infrared (MIR, λ≥2.5μm) luminescence.
Gaurav Gupta   +3 more
doaj   +1 more source

Differentiation in Architecture by Professional Designs and New Materials

open access: yesChallenging Glass Conference Proceedings, 2018
The economy globalizes. The industries concentrate. The productions become uniform. Cultural specificities disappear. About architecture and glass in architecture, it is the same phenomenon. Is this movement good or not?
Emmanuel Barrois   +2 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

A comparison study to develop the strategy for designing traditional Glass products in Egypt

open access: yesJournal of Architecture, Art & Humanistic Science, 2021
Traditional glass industry in Egypt is one of the most important traditional handicraft industries, it distinguished by high artistic and aesthetic value in production.
Sara Ahmed Zaki   +2 more
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy